Literature DB >> 7989715

Serum bile acids and cholestasis in alcoholic hepatitis. Relationship with usual liver tests and histological features.

J C Trinchet1, M F Gerhardt, B Balkau, C Munz, R E Poupon.   

Abstract

Cholestasis is a biochemical and/or histological feature observed in some patients with alcoholic liver disease and is mainly related to alcoholic hepatitis. Accumulation of bile acids in the liver could be pathogenic in alcoholic hepatitis. The aim of this study was to assay serum bile acids in patients with alcoholic hepatitis and to assess the relationship between these parameters, the usual liver tests and the histological features of alcoholic hepatitis. Thirty-six patients (median 51 years, 19 females and 17 males) with biopsy-proven alcoholic hepatitis were included in the study. Cirrhosis was present in 27 patients. Serum bile acids were assayed by high performance liquid chromatography. Three histological scores (alcoholic hepatitis, fibrosis, and cholestasis) were established on each liver sample by two independent pathologists. Serum bile acid concentrations were increased in 35 patients (97%). The median concentration of total serum bile acids was 41.6 mumol/l (range 3-293), with an increase in primary bile acids (95.7% of total bile acids), mainly chenodeoxycholic acid (median 27.5 mumol/l, range 3-184). In contrast, serum bilirubin levels were increased in only 26 patients (72%). Histological cholestasis was present in 14 patients (38%). There was no significant correlation between the alcoholic hepatitis and cholestasis scores (r = 0.01, p = 0.9). A significant correlation was noted between the alcoholic hepatitis score and serum total bile acid (r = 0.34, p = 0.04), cholic acid (r = 0.38, p = 0.03) and chenodeoxycholic acid (r = 0.32, p = 0.05) levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989715     DOI: 10.1016/s0168-8278(05)80401-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

1.  Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis.

Authors:  Katharina Brandl; Phillipp Hartmann; Lily J Jih; Donald P Pizzo; Josepmaria Argemi; Meritxell Ventura-Cots; Sally Coulter; Christopher Liddle; Lei Ling; Stephen J Rossi; Alex M DePaoli; Rohit Loomba; Wajahat Z Mehal; Derrick E Fouts; Michael R Lucey; Francisco Bosques-Padilla; Philippe Mathurin; Alexander Louvet; Guadalupe Garcia-Tsao; Elizabeth C Verna; Juan G Abraldes; Robert S Brown; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie Shawcross; Peter Stärkel; Samuel B Ho; Ramon Bataller; Bernd Schnabl
Journal:  J Hepatol       Date:  2018-04-12       Impact factor: 25.083

2.  A histologic scoring system for prognosis of patients with alcoholic hepatitis.

Authors:  José Altamirano; Rosa Miquel; Aezam Katoonizadeh; Juan G Abraldes; Andrés Duarte-Rojo; Alexandre Louvet; Salvador Augustin; Rajeshwar P Mookerjee; Javier Michelena; Thomas C Smyrk; David Buob; Emmanuelle Leteurtre; Diego Rincón; Pablo Ruiz; Juan Carlos García-Pagán; Carmen Guerrero-Marquez; Patricia D Jones; A Sidney Barritt; Vicente Arroyo; Miquel Bruguera; Rafael Bañares; Pere Ginès; Juan Caballería; Tania Roskams; Frederik Nevens; Rajiv Jalan; Philippe Mathurin; Vijay H Shah; Ramón Bataller
Journal:  Gastroenterology       Date:  2014-01-15       Impact factor: 22.682

Review 3.  Circadian clock control of hepatic lipid metabolism: role of small heterodimer partner (Shp).

Authors:  Li Wang; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-07-29       Impact factor: 2.895

4.  SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.

Authors:  Juan L García-Rodríguez; Lucía Barbier-Torres; Sara Fernández-Álvarez; Virginia Gutiérrez-de Juan; María J Monte; Emina Halilbasic; Daniel Herranz; Luis Álvarez; Patricia Aspichueta; Jose J G Marín; Michael Trauner; Jose M Mato; Manuel Serrano; Naiara Beraza; María Luz Martínez-Chantar
Journal:  Hepatology       Date:  2014-03-31       Impact factor: 17.425

5.  Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.

Authors:  Yue J Cui; Lauren M Aleksunes; Yuji Tanaka; Michael J Goedken; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2009-04-30       Impact factor: 4.849

6.  Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice.

Authors:  Noemí Cabré; Yi Duan; Cristina Llorente; Mary Conrad; Patrick Stern; Dennis Yamashita; Bernd Schnabl
Journal:  Cells       Date:  2021-06-14       Impact factor: 7.666

7.  Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis.

Authors:  Laurent Spahr; Laura Rubbia-Brandt; Muriel Genevay; Antoine Hadengue; Emiliano Giostra
Journal:  BMC Gastroenterol       Date:  2011-10-28       Impact factor: 3.067

8.  Bile acids specifically increase hepatitis C virus RNA-replication.

Authors:  Patrick Chhatwal; Dorothea Bankwitz; Juliane Gentzsch; Anne Frentzen; Philipp Schult; Volker Lohmann; Thomas Pietschmann
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

9.  Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis.

Authors:  Peng Zhou; Ruth A Ross; Cameron M Pywell; Suthat Liangpunsakul; Giles E Duffield
Journal:  Sci Rep       Date:  2014-01-16       Impact factor: 4.379

10.  A synthetic biology-based device prevents liver injury in mice.

Authors:  Peng Bai; Haifeng Ye; Mingqi Xie; Pratik Saxena; Henryk Zulewski; Ghislaine Charpin-El Hamri; Valentin Djonov; Martin Fussenegger
Journal:  J Hepatol       Date:  2016-04-09       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.